Investors Capital Advisory Services - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q4 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Investors Capital Advisory Services ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2016$251,000
+1.6%
5,562
-7.7%
0.05%
-2.0%
Q1 2016$247,000
+11.3%
6,023
+3.2%
0.05%
+14.0%
Q4 2015$222,000
-5.9%
5,835
-19.0%
0.04%
-8.5%
Q3 2015$236,000
-53.5%
7,205
-0.7%
0.05%
-49.5%
Q2 2015$507,000
-0.8%
7,253
-2.9%
0.09%
-2.1%
Q1 2015$511,000
+4.1%
7,470
+11.4%
0.10%
+1.1%
Q4 2014$491,000
+37.9%
6,703
+34.8%
0.09%
+34.3%
Q3 2014$356,000
+6.0%
4,972
+7.0%
0.07%
+29.6%
Q2 2014$336,000
-0.9%
4,648
+0.7%
0.05%
-26.0%
Q1 2014$339,000
+5.3%
4,617
-0.7%
0.07%
-2.7%
Q4 2013$322,0004,6480.08%
Other shareholders
BAXTER INTL INC shareholders Q4 2015
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders